Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer (original) (raw)
A shifting adversary: control of pancreatic cancer transcriptomic subtypes
Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment, 2022
View PDFchevron_right
A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma
Jerry Melchor
Nature Cancer, 2020
View PDFchevron_right
Genomic analyses identify molecular subtypes of pancreatic cancer
Rita Lawlor
Nature, 2016
View PDFchevron_right
Osteopontin Expression is Associated with Improved Survival in Patients with Pancreatic Adenocarcinoma
Wendy Frankel
Annals of Surgical Oncology, 2012
View PDFchevron_right
Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma
Galina Chipitsyna
Surgery, 2009
View PDFchevron_right
Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer
Mee Kang, Sangjo Han
BioMedical Engineering OnLine, 2014
View PDFchevron_right
GLI1 Inhibition Promotes Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells
L. Almada, Anne Vrabel
Cancer Research, 2012
View PDFchevron_right
A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws
Emanuela Gadaleta
Nucleic Acids Research, 2011
View PDFchevron_right
Molecular biology of pancreatic cancer
Andrew Lowy
Clinical and Translational Oncology, 2008
View PDFchevron_right
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
Kevin Vo
Proceedings of the National Academy of Sciences, 2019
View PDFchevron_right
Osteopontin but not osteonectin favors the metastatic growth of pancreatic cancer cell lines
Martin Berger
Cancer Biology & Therapy, 2010
View PDFchevron_right
Oncogenic KRAS Recruits an Expansive Transcriptional Network through Mutant p53 to Drive Pancreatic Cancer Metastasis
Shunbin Xiong
Cancer Discovery, 2021
View PDFchevron_right
Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer
Manuela Baccarini
Cancer Cell, 2013
View PDFchevron_right
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Lakshmi Jakkula
Nature Medicine, 2011
View PDFchevron_right
Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment
Antonio Giovanni Solimando
Biomedicines
View PDFchevron_right
Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions
Martin Berger
Cancer Biology & Therapy, 2005
View PDFchevron_right
Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis
Manoj Bhasin
Scientific Reports, 2019
View PDFchevron_right
Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis
Yaohe Wang
International Journal of Cancer, 2004
View PDFchevron_right
Core Signaling Pathways In Human Pancreatic Cancers Revealed by Global Genomic Analyses
Hannah Carter
science, 2008
View PDFchevron_right
Spontaneously evolved progenitor niches escape Yap oncogene addiction in advanced pancreatic ductal adenocarcinomas
Alec McIntosh
Nature Communications
View PDFchevron_right
Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia
Vlad Herlea
Hepato Gastroenterology, 2008
View PDFchevron_right
Transcriptional network governing the angiogenic switch in human pancreatic cancer
Christian Schwager
Proceedings of the National Academy of Sciences, 2007
View PDFchevron_right
Molecular and Genetic Bases of Pancreatic Cancer
Alain Gelibter
Current Drug Targets, 2012
View PDFchevron_right
Pancreatic cancer development and progression: remodeling the model
Paola Martinelli
2008
View PDFchevron_right
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
stephane garcia
2020
View PDFchevron_right
The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
Jaswinder Samra
Diseases, 2018
View PDFchevron_right
Transcriptomic Analysis Predicts Survival and Sensitivity to Anticancer Drugs of Patients with a Pancreatic Adenocarcinoma
stephane garcia
The American Journal of Pathology, 2015
View PDFchevron_right
On the Origin of Pancreatic Cancer: Molecular Tumor Subtypes in Perspective of Exocrine Cell Plasticity
Elyne Backx
Cellular and Molecular Gastroenterology and Hepatology, 2021
View PDFchevron_right
Alterations of cell signaling pathways in pancreatic cancer
Weiqi Huang
Frontiers in Bioscience, 2004
View PDFchevron_right
Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence
Linda Dorg
Cancers, 2021
View PDFchevron_right
Molecular Alterations in Pancreatic Cancer: Transfer to the Clinic
Ana García García
International Journal of Molecular Sciences, 2021
View PDFchevron_right
PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance
MOHAMEDI BRAHIM
Genes & development, 2016
View PDFchevron_right
Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases
Stefano Serra
Cancer Cell, 2019
View PDFchevron_right
Genomic and Molecular Analyses Identify Molecular Subtypes of Pancreatic Cancer Recurrence
Nigel Jamieson
Gastroenterology, 2021
View PDFchevron_right